Back to Search
Start Over
Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)
- Source :
- Clinical Microbiology and Infection, Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2011, 17 (12), pp.1882-9. ⟨10.1111/j.1469-0691.2011.03548.x⟩, Clinical Microbiology and Infection, 2011, 17 (12), pp.1882-9. ⟨10.1111/j.1469-0691.2011.03548.x⟩, Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2011, 17 (12), pp.1882-9. 〈10.1111/j.1469-0691.2011.03548.x〉
- Publication Year :
- 2011
- Publisher :
- Elsevier BV, 2011.
-
Abstract
- International audience; A prospective (2005-2007) hospital-based multicentre surveillance of EORTC/MSG-proven or probable invasive aspergillosis (IA) cases whatever the underlying diseases was implemented in 12 French academic hospitals. Admissions per hospital and transplantation procedures were obtained. Cox regression models were used to determine risk factors associated with the 12-week overall mortality. With 424 case-patients included, the median incidence/hospital was 0.271/10(3) admissions (range 0.072-0.910) without significant alteration of incidence and seasonality over time. Among the 393 adults (62% men, 56 years (16-84 years)), 15% had proven IA, 78% haematological conditions, and 92.9% had lung involvement. Acute leukaemia (34.6%) and allogeneic stem cell transplantation (21.4%) were major host factors, together with chronic lymphoproliferative disorders (21.6%), which emerged as a new high-risk group. The other risk host factors consisted of solid organ transplantation (8.7%), solid tumours (4.3%), systemic inflammatory diseases (4.6%) and chronic respiratory diseases (2.3%). Serum galactomannan tests were more often positive (≥69%) for acute leukaemia and allogeneic stem cell transplantation than for the others (
- Subjects :
- Male
Epidemiology
MESH : Prospective Studies
MESH : Aged
Aspergillosis
Mannans
0302 clinical medicine
MESH: Immunocompromised Host
Prospective Studies
MESH: Incidence
Aged, 80 and over
Invasive Pulmonary Aspergillosis
0303 health sciences
MESH: Middle Aged
Incidence
General Medicine
MESH : Incidence
3. Good health
Aspergillus
[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology
MESH: Young Adult
Drug Therapy, Combination
Microbiology (medical)
MESH: Invasive Pulmonary Aspergillosis
medicine.medical_specialty
MESH : Young Adult
03 medical and health sciences
Galactomannan
Pharmacotherapy
MESH: Mannans
MESH : Adolescent
Humans
MESH : Middle Aged
MESH : Aged, 80 and over
Aged
MESH: Adolescent
MESH: Humans
MESH : Seasons
030306 microbiology
MESH : Humans
MESH: Adult
MESH: Antifungal Agents
medicine.disease
chemistry
galactomannan
Immunology
MESH: Female
Antifungal Agents
chemistry.chemical_compound
MESH: Aged, 80 and over
Risk Factors
[ SDV.MP ] Life Sciences [q-bio]/Microbiology and Parasitology
MESH: Risk Factors
MESH : Female
030212 general & internal medicine
Prospective cohort study
MESH: Aged
Incidence (epidemiology)
MESH : Aspergillus
MESH : Immunocompromised Host
Middle Aged
MESH : Adult
MESH: Hospitals
MESH : Risk Factors
Hospitals
MESH : Hospitals
Infectious Diseases
MESH: Aspergillus
outcome
Female
France
Seasons
medicine.drug
Adult
Adolescent
MESH : Male
MESH : Antifungal Agents
Immunocompromised Host
Young Adult
Internal medicine
voriconazole
medicine
MESH : France
Voriconazole
invasive aspergillosis
business.industry
MESH : Drug Therapy, Combination
Galactose
MESH: Male
MESH: Prospective Studies
MESH: France
Transplantation
MESH: Drug Therapy, Combination
MESH : Invasive Pulmonary Aspergillosis
Caspofungin
business
MESH : Mannans
MESH: Seasons
Subjects
Details
- ISSN :
- 1198743X and 14690691
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- Clinical Microbiology and Infection
- Accession number :
- edsair.doi.dedup.....9925940f76660250a2ac79640c9a8b10